The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Fecal Pancreatic Elastase Testing Market Research Report 2022

Global Fecal Pancreatic Elastase Testing Market Research Report 2022

Publishing Date : May, 2022

License Type :
 

Report Code : 1692738

No of Pages : 90

Synopsis
Due to the COVID-19 pandemic, the global Fecal Pancreatic Elastase Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Fecal Pancreatic Elastase Testing market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Fecal Pancreatic Elastase Testing landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Fecal Pancreatic Elastase ELISA Kits accounting for % of the Fecal Pancreatic Elastase Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Fecal Pancreatic Elastase Testing include Laboratory Corporation of America® Holdings, DiaSorin, ScheBo Biotech AG, Immundiagnostik AG, Invivo Healthcare, DRG Instruments GMBH, Verisana Laboratories, BÜHLMANN Laboratories AG and CerTest Biotec S.L., etc. In terms of revenue, the global 3 largest players have a % market share of Fecal Pancreatic Elastase Testing in 2021.
This report focuses on Fecal Pancreatic Elastase Testing volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Fecal Pancreatic Elastase Testing market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Fecal Pancreatic Elastase Testing Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Fecal Pancreatic Elastase ELISA Kits
Rapid Fecal Pancreatic Elastase Kits
Segment by Application
Hospitals
Diagnostics Laboratories
Specialty Clinics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Laboratory Corporation of America® Holdings
DiaSorin
ScheBo Biotech AG
Immundiagnostik AG
Invivo Healthcare
DRG Instruments GMBH
Verisana Laboratories
BÜHLMANN Laboratories AG
CerTest Biotec S.L.
R-Biopharm AG
American Laboratory Products Company, Ltd.
Vitassay Healthcare, S.L.U.
Index
1 Fecal Pancreatic Elastase Testing Market Overview
1.1 Product Overview and Scope of Fecal Pancreatic Elastase Testing
1.2 Fecal Pancreatic Elastase Testing Segment by Type
1.2.1 Global Fecal Pancreatic Elastase Testing Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Fecal Pancreatic Elastase ELISA Kits
1.2.3 Rapid Fecal Pancreatic Elastase Kits
1.3 Fecal Pancreatic Elastase Testing Segment by Application
1.3.1 Global Fecal Pancreatic Elastase Testing Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Diagnostics Laboratories
1.3.4 Specialty Clinics
1.4 Global Fecal Pancreatic Elastase Testing Market Size Estimates and Forecasts
1.4.1 Global Fecal Pancreatic Elastase Testing Revenue 2017-2028
1.4.2 Global Fecal Pancreatic Elastase Testing Sales 2017-2028
1.4.3 Fecal Pancreatic Elastase Testing Market Size by Region: 2017 Versus 2021 Versus 2028
2 Fecal Pancreatic Elastase Testing Market Competition by Manufacturers
2.1 Global Fecal Pancreatic Elastase Testing Sales Market Share by Manufacturers (2017-2022)
2.2 Global Fecal Pancreatic Elastase Testing Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Fecal Pancreatic Elastase Testing Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Fecal Pancreatic Elastase Testing Manufacturing Sites, Area Served, Product Type
2.5 Fecal Pancreatic Elastase Testing Market Competitive Situation and Trends
2.5.1 Fecal Pancreatic Elastase Testing Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Fecal Pancreatic Elastase Testing Players Market Share by Revenue
2.5.3 Global Fecal Pancreatic Elastase Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fecal Pancreatic Elastase Testing Retrospective Market Scenario by Region
3.1 Global Fecal Pancreatic Elastase Testing Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Fecal Pancreatic Elastase Testing Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Fecal Pancreatic Elastase Testing Market Facts & Figures by Country
3.3.1 North America Fecal Pancreatic Elastase Testing Sales by Country
3.3.2 North America Fecal Pancreatic Elastase Testing Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Fecal Pancreatic Elastase Testing Market Facts & Figures by Country
3.4.1 Europe Fecal Pancreatic Elastase Testing Sales by Country
3.4.2 Europe Fecal Pancreatic Elastase Testing Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Fecal Pancreatic Elastase Testing Market Facts & Figures by Region
3.5.1 Asia Pacific Fecal Pancreatic Elastase Testing Sales by Region
3.5.2 Asia Pacific Fecal Pancreatic Elastase Testing Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Fecal Pancreatic Elastase Testing Market Facts & Figures by Country
3.6.1 Latin America Fecal Pancreatic Elastase Testing Sales by Country
3.6.2 Latin America Fecal Pancreatic Elastase Testing Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Fecal Pancreatic Elastase Testing Market Facts & Figures by Country
3.7.1 Middle East and Africa Fecal Pancreatic Elastase Testing Sales by Country
3.7.2 Middle East and Africa Fecal Pancreatic Elastase Testing Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Fecal Pancreatic Elastase Testing Historic Market Analysis by Type
4.1 Global Fecal Pancreatic Elastase Testing Sales Market Share by Type (2017-2022)
4.2 Global Fecal Pancreatic Elastase Testing Revenue Market Share by Type (2017-2022)
4.3 Global Fecal Pancreatic Elastase Testing Price by Type (2017-2022)
5 Global Fecal Pancreatic Elastase Testing Historic Market Analysis by Application
5.1 Global Fecal Pancreatic Elastase Testing Sales Market Share by Application (2017-2022)
5.2 Global Fecal Pancreatic Elastase Testing Revenue Market Share by Application (2017-2022)
5.3 Global Fecal Pancreatic Elastase Testing Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Laboratory Corporation of America® Holdings
6.1.1 Laboratory Corporation of America® Holdings Corporation Information
6.1.2 Laboratory Corporation of America® Holdings Description and Business Overview
6.1.3 Laboratory Corporation of America® Holdings Fecal Pancreatic Elastase Testing Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Laboratory Corporation of America® Holdings Fecal Pancreatic Elastase Testing Product Portfolio
6.1.5 Laboratory Corporation of America® Holdings Recent Developments/Updates
6.2 DiaSorin
6.2.1 DiaSorin Corporation Information
6.2.2 DiaSorin Description and Business Overview
6.2.3 DiaSorin Fecal Pancreatic Elastase Testing Sales, Revenue and Gross Margin (2017-2022)
6.2.4 DiaSorin Fecal Pancreatic Elastase Testing Product Portfolio
6.2.5 DiaSorin Recent Developments/Updates
6.3 ScheBo Biotech AG
6.3.1 ScheBo Biotech AG Corporation Information
6.3.2 ScheBo Biotech AG Description and Business Overview
6.3.3 ScheBo Biotech AG Fecal Pancreatic Elastase Testing Sales, Revenue and Gross Margin (2017-2022)
6.3.4 ScheBo Biotech AG Fecal Pancreatic Elastase Testing Product Portfolio
6.3.5 ScheBo Biotech AG Recent Developments/Updates
6.4 Immundiagnostik AG
6.4.1 Immundiagnostik AG Corporation Information
6.4.2 Immundiagnostik AG Description and Business Overview
6.4.3 Immundiagnostik AG Fecal Pancreatic Elastase Testing Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Immundiagnostik AG Fecal Pancreatic Elastase Testing Product Portfolio
6.4.5 Immundiagnostik AG Recent Developments/Updates
6.5 Invivo Healthcare
6.5.1 Invivo Healthcare Corporation Information
6.5.2 Invivo Healthcare Description and Business Overview
6.5.3 Invivo Healthcare Fecal Pancreatic Elastase Testing Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Invivo Healthcare Fecal Pancreatic Elastase Testing Product Portfolio
6.5.5 Invivo Healthcare Recent Developments/Updates
6.6 DRG Instruments GMBH
6.6.1 DRG Instruments GMBH Corporation Information
6.6.2 DRG Instruments GMBH Description and Business Overview
6.6.3 DRG Instruments GMBH Fecal Pancreatic Elastase Testing Sales, Revenue and Gross Margin (2017-2022)
6.6.4 DRG Instruments GMBH Fecal Pancreatic Elastase Testing Product Portfolio
6.6.5 DRG Instruments GMBH Recent Developments/Updates
6.7 Verisana Laboratories
6.6.1 Verisana Laboratories Corporation Information
6.6.2 Verisana Laboratories Description and Business Overview
6.6.3 Verisana Laboratories Fecal Pancreatic Elastase Testing Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Verisana Laboratories Fecal Pancreatic Elastase Testing Product Portfolio
6.7.5 Verisana Laboratories Recent Developments/Updates
6.8 BÜHLMANN Laboratories AG
6.8.1 BÜHLMANN Laboratories AG Corporation Information
6.8.2 BÜHLMANN Laboratories AG Description and Business Overview
6.8.3 BÜHLMANN Laboratories AG Fecal Pancreatic Elastase Testing Sales, Revenue and Gross Margin (2017-2022)
6.8.4 BÜHLMANN Laboratories AG Fecal Pancreatic Elastase Testing Product Portfolio
6.8.5 BÜHLMANN Laboratories AG Recent Developments/Updates
6.9 CerTest Biotec S.L.
6.9.1 CerTest Biotec S.L. Corporation Information
6.9.2 CerTest Biotec S.L. Description and Business Overview
6.9.3 CerTest Biotec S.L. Fecal Pancreatic Elastase Testing Sales, Revenue and Gross Margin (2017-2022)
6.9.4 CerTest Biotec S.L. Fecal Pancreatic Elastase Testing Product Portfolio
6.9.5 CerTest Biotec S.L. Recent Developments/Updates
6.10 R-Biopharm AG
6.10.1 R-Biopharm AG Corporation Information
6.10.2 R-Biopharm AG Description and Business Overview
6.10.3 R-Biopharm AG Fecal Pancreatic Elastase Testing Sales, Revenue and Gross Margin (2017-2022)
6.10.4 R-Biopharm AG Fecal Pancreatic Elastase Testing Product Portfolio
6.10.5 R-Biopharm AG Recent Developments/Updates
6.11 American Laboratory Products Company, Ltd.
6.11.1 American Laboratory Products Company, Ltd. Corporation Information
6.11.2 American Laboratory Products Company, Ltd. Fecal Pancreatic Elastase Testing Description and Business Overview
6.11.3 American Laboratory Products Company, Ltd. Fecal Pancreatic Elastase Testing Sales, Revenue and Gross Margin (2017-2022)
6.11.4 American Laboratory Products Company, Ltd. Fecal Pancreatic Elastase Testing Product Portfolio
6.11.5 American Laboratory Products Company, Ltd. Recent Developments/Updates
6.12 Vitassay Healthcare, S.L.U.
6.12.1 Vitassay Healthcare, S.L.U. Corporation Information
6.12.2 Vitassay Healthcare, S.L.U. Fecal Pancreatic Elastase Testing Description and Business Overview
6.12.3 Vitassay Healthcare, S.L.U. Fecal Pancreatic Elastase Testing Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Vitassay Healthcare, S.L.U. Fecal Pancreatic Elastase Testing Product Portfolio
6.12.5 Vitassay Healthcare, S.L.U. Recent Developments/Updates
7 Fecal Pancreatic Elastase Testing Manufacturing Cost Analysis
7.1 Fecal Pancreatic Elastase Testing Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Fecal Pancreatic Elastase Testing
7.4 Fecal Pancreatic Elastase Testing Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Fecal Pancreatic Elastase Testing Distributors List
8.3 Fecal Pancreatic Elastase Testing Customers
9 Fecal Pancreatic Elastase Testing Market Dynamics
9.1 Fecal Pancreatic Elastase Testing Industry Trends
9.2 Fecal Pancreatic Elastase Testing Market Drivers
9.3 Fecal Pancreatic Elastase Testing Market Challenges
9.4 Fecal Pancreatic Elastase Testing Market Restraints
10 Global Market Forecast
10.1 Fecal Pancreatic Elastase Testing Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Fecal Pancreatic Elastase Testing by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Fecal Pancreatic Elastase Testing by Type (2023-2028)
10.2 Fecal Pancreatic Elastase Testing Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Fecal Pancreatic Elastase Testing by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Fecal Pancreatic Elastase Testing by Application (2023-2028)
10.3 Fecal Pancreatic Elastase Testing Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Fecal Pancreatic Elastase Testing by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Fecal Pancreatic Elastase Testing by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Fecal Pancreatic Elastase Testing Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Fecal Pancreatic Elastase Testing Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Fecal Pancreatic Elastase Testing Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Fecal Pancreatic Elastase Testing Market Competitive Situation by Manufacturers in 2021
Table 5. Global Fecal Pancreatic Elastase Testing Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Fecal Pancreatic Elastase Testing Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Fecal Pancreatic Elastase Testing Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Fecal Pancreatic Elastase Testing Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Fecal Pancreatic Elastase Testing Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Fecal Pancreatic Elastase Testing Manufacturing Sites and Area Served
Table 11. Manufacturers Fecal Pancreatic Elastase Testing Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Fecal Pancreatic Elastase Testing by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fecal Pancreatic Elastase Testing as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Fecal Pancreatic Elastase Testing Sales by Region (2017-2022) & (K Units)
Table 16. Global Fecal Pancreatic Elastase Testing Sales Market Share by Region (2017-2022)
Table 17. Global Fecal Pancreatic Elastase Testing Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Fecal Pancreatic Elastase Testing Revenue Market Share by Region (2017-2022)
Table 19. North America Fecal Pancreatic Elastase Testing Sales by Country (2017-2022) & (K Units)
Table 20. North America Fecal Pancreatic Elastase Testing Sales Market Share by Country (2017-2022)
Table 21. North America Fecal Pancreatic Elastase Testing Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Fecal Pancreatic Elastase Testing Revenue Market Share by Country (2017-2022)
Table 23. Europe Fecal Pancreatic Elastase Testing Sales by Country (2017-2022) & (K Units)
Table 24. Europe Fecal Pancreatic Elastase Testing Sales Market Share by Country (2017-2022)
Table 25. Europe Fecal Pancreatic Elastase Testing Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Fecal Pancreatic Elastase Testing Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Fecal Pancreatic Elastase Testing Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Fecal Pancreatic Elastase Testing Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Fecal Pancreatic Elastase Testing Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Fecal Pancreatic Elastase Testing Revenue Market Share by Region (2017-2022)
Table 31. Latin America Fecal Pancreatic Elastase Testing Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Fecal Pancreatic Elastase Testing Sales Market Share by Country (2017-2022)
Table 33. Latin America Fecal Pancreatic Elastase Testing Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Fecal Pancreatic Elastase Testing Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Fecal Pancreatic Elastase Testing Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Fecal Pancreatic Elastase Testing Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Fecal Pancreatic Elastase Testing Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Fecal Pancreatic Elastase Testing Revenue Market Share by Country (2017-2022)
Table 39. Global Fecal Pancreatic Elastase Testing Sales by Type (2017-2022) & (K Units)
Table 40. Global Fecal Pancreatic Elastase Testing Sales Market Share by Type (2017-2022)
Table 41. Global Fecal Pancreatic Elastase Testing Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Fecal Pancreatic Elastase Testing Revenue Share by Type (2017-2022)
Table 43. Global Fecal Pancreatic Elastase Testing Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Fecal Pancreatic Elastase Testing Sales (K Units) by Application (2017-2022)
Table 45. Global Fecal Pancreatic Elastase Testing Sales Market Share by Application (2017-2022)
Table 46. Global Fecal Pancreatic Elastase Testing Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Fecal Pancreatic Elastase Testing Revenue Share by Application (2017-2022)
Table 48. Global Fecal Pancreatic Elastase Testing Price by Application (2017-2022) & (US$/Unit)
Table 49. Laboratory Corporation of America® Holdings Corporation Information
Table 50. Laboratory Corporation of America® Holdings Description and Business Overview
Table 51. Laboratory Corporation of America® Holdings Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Laboratory Corporation of America® Holdings Fecal Pancreatic Elastase Testing Product
Table 53. Laboratory Corporation of America® Holdings Recent Developments/Updates
Table 54. DiaSorin Corporation Information
Table 55. DiaSorin Description and Business Overview
Table 56. DiaSorin Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. DiaSorin Fecal Pancreatic Elastase Testing Product
Table 58. DiaSorin Recent Developments/Updates
Table 59. ScheBo Biotech AG Corporation Information
Table 60. ScheBo Biotech AG Description and Business Overview
Table 61. ScheBo Biotech AG Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. ScheBo Biotech AG Fecal Pancreatic Elastase Testing Product
Table 63. ScheBo Biotech AG Recent Developments/Updates
Table 64. Immundiagnostik AG Corporation Information
Table 65. Immundiagnostik AG Description and Business Overview
Table 66. Immundiagnostik AG Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Immundiagnostik AG Fecal Pancreatic Elastase Testing Product
Table 68. Immundiagnostik AG Recent Developments/Updates
Table 69. Invivo Healthcare Corporation Information
Table 70. Invivo Healthcare Description and Business Overview
Table 71. Invivo Healthcare Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Invivo Healthcare Fecal Pancreatic Elastase Testing Product
Table 73. Invivo Healthcare Recent Developments/Updates
Table 74. DRG Instruments GMBH Corporation Information
Table 75. DRG Instruments GMBH Description and Business Overview
Table 76. DRG Instruments GMBH Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. DRG Instruments GMBH Fecal Pancreatic Elastase Testing Product
Table 78. DRG Instruments GMBH Recent Developments/Updates
Table 79. Verisana Laboratories Corporation Information
Table 80. Verisana Laboratories Description and Business Overview
Table 81. Verisana Laboratories Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Verisana Laboratories Fecal Pancreatic Elastase Testing Product
Table 83. Verisana Laboratories Recent Developments/Updates
Table 84. BÜHLMANN Laboratories AG Corporation Information
Table 85. BÜHLMANN Laboratories AG Description and Business Overview
Table 86. BÜHLMANN Laboratories AG Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. BÜHLMANN Laboratories AG Fecal Pancreatic Elastase Testing Product
Table 88. BÜHLMANN Laboratories AG Recent Developments/Updates
Table 89. CerTest Biotec S.L. Corporation Information
Table 90. CerTest Biotec S.L. Description and Business Overview
Table 91. CerTest Biotec S.L. Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. CerTest Biotec S.L. Fecal Pancreatic Elastase Testing Product
Table 93. CerTest Biotec S.L. Recent Developments/Updates
Table 94. R-Biopharm AG Corporation Information
Table 95. R-Biopharm AG Description and Business Overview
Table 96. R-Biopharm AG Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. R-Biopharm AG Fecal Pancreatic Elastase Testing Product
Table 98. R-Biopharm AG Recent Developments/Updates
Table 99. American Laboratory Products Company, Ltd. Corporation Information
Table 100. American Laboratory Products Company, Ltd. Description and Business Overview
Table 101. American Laboratory Products Company, Ltd. Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. American Laboratory Products Company, Ltd. Fecal Pancreatic Elastase Testing Product
Table 103. American Laboratory Products Company, Ltd. Recent Developments/Updates
Table 104. Vitassay Healthcare, S.L.U. Corporation Information
Table 105. Vitassay Healthcare, S.L.U. Description and Business Overview
Table 106. Vitassay Healthcare, S.L.U. Fecal Pancreatic Elastase Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Vitassay Healthcare, S.L.U. Fecal Pancreatic Elastase Testing Product
Table 108. Vitassay Healthcare, S.L.U. Recent Developments/Updates
Table 109. Production Base and Market Concentration Rate of Raw Material
Table 110. Key Suppliers of Raw Materials
Table 111. Fecal Pancreatic Elastase Testing Distributors List
Table 112. Fecal Pancreatic Elastase Testing Customers List
Table 113. Fecal Pancreatic Elastase Testing Market Trends
Table 114. Fecal Pancreatic Elastase Testing Market Drivers
Table 115. Fecal Pancreatic Elastase Testing Market Challenges
Table 116. Fecal Pancreatic Elastase Testing Market Restraints
Table 117. Global Fecal Pancreatic Elastase Testing Sales Forecast by Type (2023-2028) & (K Units)
Table 118. Global Fecal Pancreatic Elastase Testing Sales Market Share Forecast by Type (2023-2028)
Table 119. Global Fecal Pancreatic Elastase Testing Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 120. Global Fecal Pancreatic Elastase Testing Revenue Market Share Forecast by Type (2023-2028)
Table 121. Global Fecal Pancreatic Elastase Testing Sales Forecast by Application (2023-2028) & (K Units)
Table 122. Global Fecal Pancreatic Elastase Testing Sales Market Share Forecast by Application (2023-2028)
Table 123. Global Fecal Pancreatic Elastase Testing Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 124. Global Fecal Pancreatic Elastase Testing Revenue Market Share Forecast by Application (2023-2028)
Table 125. Global Fecal Pancreatic Elastase Testing Sales Forecast by Region (2023-2028) & (K Units)
Table 126. Global Fecal Pancreatic Elastase Testing Sales Market Share Forecast by Region (2023-2028)
Table 127. Global Fecal Pancreatic Elastase Testing Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 128. Global Fecal Pancreatic Elastase Testing Revenue Market Share Forecast by Region (2023-2028)
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Fecal Pancreatic Elastase Testing
Figure 2. Global Fecal Pancreatic Elastase Testing Market Share by Type in 2021 & 2028
Figure 3. Fecal Pancreatic Elastase ELISA Kits Product Picture
Figure 4. Rapid Fecal Pancreatic Elastase Kits Product Picture
Figure 5. Global Fecal Pancreatic Elastase Testing Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Diagnostics Laboratories
Figure 8. Specialty Clinics
Figure 9. Global Fecal Pancreatic Elastase Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Fecal Pancreatic Elastase Testing Market Size (2017-2028) & (US$ Million)
Figure 11. Global Fecal Pancreatic Elastase Testing Sales (2017-2028) & (K Units)
Figure 12. Fecal Pancreatic Elastase Testing Sales Share by Manufacturers in 2021
Figure 13. Global Fecal Pancreatic Elastase Testing Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Fecal Pancreatic Elastase Testing Players: Market Share by Revenue in 2021
Figure 15. Fecal Pancreatic Elastase Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Fecal Pancreatic Elastase Testing Sales Market Share by Region (2017-2022)
Figure 17. Global Fecal Pancreatic Elastase Testing Sales Market Share by Region in 2021
Figure 18. Global Fecal Pancreatic Elastase Testing Revenue Market Share by Region (2017-2022)
Figure 19. Global Fecal Pancreatic Elastase Testing Revenue Market Share by Region in 2021
Figure 20. United States Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Colombia Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE Fecal Pancreatic Elastase Testing Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Fecal Pancreatic Elastase Testing by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Fecal Pancreatic Elastase Testing
Figure 45. Manufacturing Process Analysis of Fecal Pancreatic Elastase Testing
Figure 46. Fecal Pancreatic Elastase Testing Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’